Targeting senescent cells for vascular aging and related diseases

J Mol Cell Cardiol. 2022 Jan:162:43-52. doi: 10.1016/j.yjmcc.2021.08.009. Epub 2021 Aug 23.

Abstract

Cardiovascular diseases are a serious threat to human health, especially in the elderly. Vascular aging makes people more susceptible to cardiovascular diseases due to significant dysfunction or senescence of vascular cells and maladaptation of vascular structure and function; moreover, vascular aging is currently viewed as a modifiable cardiovascular risk factor. To emphasize the relationship between senescent cells and vascular aging, we first summarize the roles of senescent vascular cells (endothelial cells, smooth muscle cells and immune cells) in the vascular aging process and inducers that contribute to cellular senescence. Then, we present potential strategies for directly targeting senescent cells (senotherapy) or preventively targeting senescence inducers (senoprevention) to delay vascular aging and the development of age-related vascular diseases. Finally, based on recent research, we note some important questions that still need to be addressed in the future.

Keywords: Cell senescence; Senescence inducers; Senoprevention; Senotherapy; Vascular aging.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Aging
  • Cardiovascular Diseases* / etiology
  • Cellular Senescence
  • Endothelial Cells*
  • Humans
  • Myocytes, Smooth Muscle